More Filters

Defective Drug Recalls Lawyer Portland

Defective Drug Recalls Lawyer Portland

Douglas Oh-Keith

Defective Drug Recalls Lawyer

Doug Oh-Keith is a dedicated advocate for injured people. For twenty two years, Doug has practiced personal injury and wrongful death law in Oregon and California. Prior to that, Doug worked as an insurance defense attorney – giving him a valuable perspective on insurance company lawyers’ methods and tactics personal injury law.

The process of filing a personal injury claim can be confusing. Doug and the attorneys at D’Amore Law Group are sensitive to their clients’ feelings of intimidation and not knowing the process. Most of our clients have never been represented by an attorney. “We strive to give our clients the support they need, while helping them prepare the strongest possible case,” Oh-Keith states.

Jina Clark

Defective Drug Recalls Lawyer

Ms. Clark graduated from the University of California, Hastings College of Law law school with the goal of working as a lawyer in criminal defense. For the first four years of her practice she worked primarily on both court-appointed and privately retained criminal defense cases, which helped her to gain valuable trial experience.

After multiple auto accidents early in her career, she suffered compounded whiplash. (See long version) While finding her way through a maze of medical providers and working with the insurance companies to receive payment for her injuries, she became interested in personal injury law. Since then, Ms. Clark has expanded her practice to include a combination of civil and criminal practice areas in Portland, Oregon, and Washington State.

JON M. FRIEDMAN

Defective Drug Recalls Lawyer

Jon M. Friedman has been assisting people who have been injured by negligent drivers, doctors, and lawyers in state and federal courts since 1984, and prides himself on providing personal attention to each client to resolve cases in a fast, fair, and complete way.

Jon grew up near Chicago, where he graduated from a public high school in 1976, before attending Carleton College in Northfield, Minnesota where he graduated in 1980 with a Bachelor of Arts in economics.

Following his heart, Jon spent 1980-81 cleaning the undersides of airplanes while becoming a commercial-rated pilot and a certified flight instructor, both instrument and airplane, and continues to enjoy teaching and flying in cloudy or foggy conditions, using only the airplane’s instruments to maintain safe flight.

MARC A. JOHNSTON

Defective Drug Recalls Lawyer

Attorney Johnston’s 15+ year legal career has been dedicated to representing individuals and their families who have been injured or killed by negligent drivers and corporations. His focus on trial law creates the backbone of the Johnston Law Firm — a firm that is ready to go the distance in seeking justice for its clients.

From 2006 to 2009, Marc was the founder and head coach of the Reed College Mock Trial Program, where he taught and shared litigation skills with college students. After starting the program, Mr. Johnston led the team to a national competition, where it received an honorable mention in only the second year of the program’s existence.

Marc is a board member of the Oregon New Lawyer Division, where he represents more than one-third of the attorneys in the state. Johnston Law Firm, P.C. is also proud of its work on the board of the Loan Repayment Assistance Program (LRAP), which assists lower income attorneys to continue their work in public service sectors.

Aaron Tillmann, Esq.

Defective Drug Recalls Lawyer

Aaron Tillmann is the founder and managing partner of Tillmann Law Personal Injury Lawyers.  The law firm advocates for the injured and represents those individuals seeking compensation from insurance companies, businesses, and individuals that are liable for hurting others.

His practice focuses on personal injury, including Portland car accidents, pedestrians, cyclists, and motorcyclists hit by vehicles, trucking and tractor-trailer cases, wrongful death, and medical malpractice.

Mr. Tillmann is a Portland personal injury attorney licensed to practice in Oregon and Utah and is admitted to practice before all state courts, the federal district of Oregon, and Utah.

Mr. Tillmann is a graduate of Gonzaga University School of Law in Spokane, Washington.  He obtained an additional Masters in Law from the Boston University School of Law.

Jeremiah Ross

Defective Drug Recalls Lawyer

Jeremiah Ross became an attorney to fight for others.  The son of a career sailor, Jeremiah grew up living around the world until his family finally settled down on the coast.  

At the age of 17 years old, he graduated from high school and left his job at a roofing company to serve in the Marine Corps Infantry.  Jeremiah left the Marine Corps and served in the Oregon National Guard.

Jeremiah attended California Western School of Law. In law school, Jeremiah interned for various public defenders’ offices, and was later hired as a prosecutor in 2007.   While serving as a prosecutor, Jeremiah conducted dozens of Jury trials and numerous hearings. In 2011 Jeremiah left the District Attorney’s office to pursue his dream of running his own law firm. 

In his spare time Jeremiah enjoys spending time with his beautiful wife and his awesome kids.  He is an avid surfer, he enjoys hiking, running, snow-boarding, and cycling.

Richard Rizk

Defective Drug Recalls Lawyer

Richard Rizk, senior lawyer at Rizk Law, was born in Manhattan to young medical professionals. His father, a doctor who immigrated from Egypt, and his mother, a nurse from small-town Indiana, lived in a small Bronx apartment on a shoestring budget when they welcomed their baby boy. Unfortunately, it wouldn’t be long after Richard’s birth that his family would be forced out of the country due to a lapse in his father’s visa.

Eventually the Rizk family would settle in northern Illinois. His father developed a successful medical practice which allowed the family to travel the world. Together, the family would explore Europe, the Caribbean, and the Middle East. However, tension began to build between Richard’s parents. During a trip to England in the 1970s parental tension peaked leading to his parents’ divorce.

Meanwhile, in grade school, Richard faced relentless harassment from other children for stuttering. On one occasion, his third-grade teacher even singled him out as disabled because of his speech impediment. From that time on, Richard took speech therapy sessions after school while the other kids played outside. By the time he reached his teens, the stutter had disappeared.

Which Agency Is Responsible for Recalling a Medication?

Medication recalls are a critical aspect of public health and safety. When a medication is found to be defective, contaminated, mislabeled, or otherwise unsafe, it must be swiftly removed from the market to protect patients and consumers. But who is ultimately responsible for this process? The answer varies depending on the country, but the general framework involves both the manufacturer (or distributor) of the medication and the national regulatory agency. This article explores the recall process, the roles of different agencies, and how recalls are managed around the world.


Understanding Medication Recalls

A medication recall is an action taken to remove a drug from the market because it poses a risk to health or fails to meet regulatory standards. Reasons for recalls can include contamination (such as the presence of bacteria or foreign particles), labeling errors, incorrect potency, or discovery of previously unknown side effects. Recalls are classified based on the level of risk they present, ranging from minor labeling issues to serious threats to life.


The Role of the Manufacturer

In most cases, the manufacturer or distributor of a medication is the first to discover a problem. This could happen through their own quality control processes, reports from healthcare professionals, or complaints from patients. When a defect or risk is identified, it is the manufacturer’s ethical and legal responsibility to notify the appropriate regulatory agency and initiate a recall.

Manufacturers are expected to act quickly to prevent harm. They must trace the distribution of the affected product, notify wholesalers, pharmacies, and healthcare providers, and provide instructions for returning or disposing of the medication. Transparency and timely communication are essential to ensure that the recall is effective and that patients are not exposed to unnecessary risk.


The Regulatory Agency: Oversight and Enforcement

While manufacturers are responsible for initiating recalls, national regulatory agencies oversee the entire process. Their role is to ensure that recalls are conducted properly, efficiently, and in a way that protects public health. Let’s examine how this works in several major countries:

United States: Food and Drug Administration (FDA)

In the United States, the Food and Drug Administration (FDA) is the primary agency responsible for overseeing medication recalls. Here’s how the process typically works:

  • Initiation: Most recalls are voluntary, meaning the manufacturer or distributor starts the process after discovering a problem.

  • Notification: The manufacturer must notify the FDA, which then evaluates the risk and determines the appropriate classification for the recall:

    • Class I: A dangerous or defective product that could cause serious health problems or death.

    • Class II: A product that might cause a temporary health problem or pose only a slight threat.

    • Class III: A product unlikely to cause any adverse health reaction but violates FDA labeling or manufacturing laws.

  • Oversight: The FDA monitors the recall, ensuring the manufacturer’s actions are adequate. The agency may inspect facilities, review records, and require updates on the recall’s progress.

  • Enforcement: If a manufacturer does not voluntarily recall a dangerous product, the FDA has the authority to mandate a recall or seek a court order.

  • Public Notification: For significant recalls, the FDA issues press releases and updates its website to inform healthcare professionals and the public.

India: Central Drugs Standard Control Organization (CDSCO)

In India, the Central Drugs Standard Control Organization (CDSCO) is the equivalent regulatory authority:

  • Initiation: Recalls can be voluntary or ordered by the CDSCO or State Licensing Authorities (SLA) if a drug is found to be substandard, adulterated, or unsafe.

  • Coordination: The CDSCO coordinates with manufacturers, distributors, and state authorities to ensure the recall reaches all levels of the supply chain.

  • Monitoring: The agency monitors the recall’s effectiveness, ensuring that all affected products are removed from circulation.

  • Public Communication: The CDSCO may issue public advisories to alert healthcare professionals and consumers.

Other Countries

  • Australia: The Therapeutic Goods Administration (TGA) manages medicine recalls, working closely with sponsors and manufacturers.

  • European Union: The European Medicines Agency (EMA) and national agencies share responsibility, with similar processes for notification, classification, and oversight.


The Recall Process: Step by Step

  1. Detection: A problem is identified by the manufacturer, healthcare provider, regulatory agency, or consumer.

  2. Notification: The manufacturer notifies the regulatory agency and initiates the recall.

  3. Assessment: The agency assesses the risk and classifies the recall.

  4. Communication: All stakeholders, including distributors, pharmacies, hospitals, and sometimes the public, are notified.

  5. Action: The affected product is removed from shelves, and patients are advised on next steps.

  6. Follow-up: The agency monitors the recall to ensure effectiveness and may conduct inspections or request reports.

  7. Closure: Once the recall is complete and the risk is mitigated, the agency closes the case.


Why Are Regulatory Agencies Essential?

Regulatory agencies play a crucial role in ensuring that recalls are not only initiated but also completed effectively. They provide oversight, enforce compliance, and maintain public trust in the safety of the medication supply. Without their intervention, recalls might be incomplete or delayed, putting patients at risk.


Conclusion

In summary, the responsibility for recalling a medication is a shared one. Manufacturers are expected to act swiftly when a problem is discovered, but regulatory agencies such as the FDA (United States), CDSCO (India), and TGA (Australia) provide the necessary oversight, enforcement, and public communication to ensure that recalls protect public health. The collaboration between industry and government is essential for maintaining the safety and integrity of the global medication supply.